Ethical issues in vaccine trial participation by adolescents: qualitative insights on family decision making from a human papillomavirus vaccine trial in Tanzania
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Ethical issues in vaccine trial participation by adolescents: qualitative insights on family decision making from a human papillomavirus vaccine trial in Tanzania ; volume:25 ; number:1 ; day:20 ; month:11 ; year:2024 ; pages:1-16 ; date:12.2024
BMC medical ethics ; 25, Heft 1 (20.11.2024), 1-16, 12.2024
- Creator
-
Frost, Lucy
Erio, Ms Tusajigwe
Whitworth, Hilary
Marwerwe, Ms Graca
Hayes, Richard
Baisley, Kathy
SanJosé, Silvia de
Watson-Jones, Deborah
Mitchell, Kirstin
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12910-024-01122-z
- URN
-
urn:nbn:de:101:1-2502062100101.074079183694
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:39 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Frost, Lucy
- Erio, Ms Tusajigwe
- Whitworth, Hilary
- Marwerwe, Ms Graca
- Hayes, Richard
- Baisley, Kathy
- SanJosé, Silvia de
- Watson-Jones, Deborah
- Mitchell, Kirstin
- SpringerLink (Online service)
Other Objects (12)
Motivations for paediatric vaccine trial participation
Post-trial Access in Maternal Vaccine Trials
The aftermath of the Merck's HIV vaccine trial
Methodological and ethical issues in research using social media: a metamethod of Human Papillomavirus vaccine studies
A qualitative evaluation of volunteers' experiences in a phase I/II HIV vaccine trial in Tanzania
Human papillomavirus infection mechanism and vaccine of vulva carcinoma
Modeling adaptive response profiles in a vaccine clinical trial
P15-14. Assuring data quality of the phase III vaccine trial of ALVAC vaccine priming and AIDSVAX vaccine boosting in Thailand
New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants
Cost-effectiveness of a tetravalent human papillomavirus vaccine in Germany
Cost-effectiveness of a tetravalent human papillomavirus vaccine in Germany
Differential long-term bivalent HPV vaccine cross-protection by variants in the Costa Rica HPV vaccine trial
Motivations for paediatric vaccine trial participation
Post-trial Access in Maternal Vaccine Trials
The aftermath of the Merck's HIV vaccine trial
Methodological and ethical issues in research using social media: a metamethod of Human Papillomavirus vaccine studies
A qualitative evaluation of volunteers' experiences in a phase I/II HIV vaccine trial in Tanzania
Human papillomavirus infection mechanism and vaccine of vulva carcinoma
Modeling adaptive response profiles in a vaccine clinical trial
P15-14. Assuring data quality of the phase III vaccine trial of ALVAC vaccine priming and AIDSVAX vaccine boosting in Thailand
New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants
Cost-effectiveness of a tetravalent human papillomavirus vaccine in Germany
Cost-effectiveness of a tetravalent human papillomavirus vaccine in Germany
Differential long-term bivalent HPV vaccine cross-protection by variants in the Costa Rica HPV vaccine trial
Motivations for paediatric vaccine trial participation
Post-trial Access in Maternal Vaccine Trials
The aftermath of the Merck's HIV vaccine trial
Methodological and ethical issues in research using social media: a metamethod of Human Papillomavirus vaccine studies
A qualitative evaluation of volunteers' experiences in a phase I/II HIV vaccine trial in Tanzania
Human papillomavirus infection mechanism and vaccine of vulva carcinoma
Modeling adaptive response profiles in a vaccine clinical trial
P15-14. Assuring data quality of the phase III vaccine trial of ALVAC vaccine priming and AIDSVAX vaccine boosting in Thailand
New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants
Cost-effectiveness of a tetravalent human papillomavirus vaccine in Germany
Cost-effectiveness of a tetravalent human papillomavirus vaccine in Germany